• Skip to main content

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

News

News

SK Capital Partners / January 9, 2023

Jan 09, 2023 / Lacerta

Lacerta Group Announces Acquisition of Portage Plastics Assets

Strategic acquisition will expand Lacerta’s production footprint into the Midwest to further enhance industry-leading customer service MANSFIELD, MA. – …

➞

SK Capital Partners / January 3, 2023

Jan 03, 2023 / SK Capital

SK Capital Announces Promotions

New York, January 3, 2023 – SK Capital Partners, LP, a private investment firm focused on the specialty materials, specialty chemicals, and pharmaceuticals …

➞

SK Capital Partners / December 1, 2022

Dec 01, 2022 / SK Capital

SK Capital Partners and Edgewater Capital Partners Close Acquisition of Crystals Business from Saint-Gobain

Business to be Rebranded as Luxium Solutions Hiram, Ohio- December 1, 2022 – Funds advised by SK Capital Partners, LP (“SK Capital”) and Edgewater Capital …

➞

SK Capital Partners / October 5, 2022

Oct 05, 2022 / Ipackchem

IPACKCHEM Acquires TPG Plastics LLC to Bring its Barrier Packaging to North America

The transaction fulfills IPACKCHEM’s vision of producing specialized barrier containers on every major continent for its multi-national customers Paris, …

➞

SK Capital Partners / October 5, 2022

Oct 05, 2022 /

Deltech Holdings Completes the Acquisition of StanChem

Baton Rouge, LA, October 4, 2022 —Deltech Holdings, LLC (“Deltech”), a leading producer of high-performance aromatic monomers, specialized crystal polystyrene, …

➞

SK Capital Partners / September 28, 2022

Sep 28, 2022 / Apotex, SK Capital

SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals

Investment from SK Capital to support Apotex’s next phase of growth and continued innovation for patient affordability An affiliate of funds advised by SK …

➞

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 25
  • ➞

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login